MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 93 filers reported holding MAGENTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,000 | -38.6% | 14,854 | -6.6% | 0.00% | – |
| Q4 2021 | $70,000 | -41.2% | 15,899 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $119,000 | -27.4% | 16,375 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $164,000 | +14.7% | 16,764 | +38.9% | 0.00% | 0.0% |
| Q1 2021 | $143,000 | +52.1% | 12,065 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +11.9% | 12,034 | -2.8% | 0.00% | – |
| Q3 2020 | $84,000 | +7.7% | 12,379 | +19.5% | 0.00% | – |
| Q2 2020 | $78,000 | +9.9% | 10,360 | -8.9% | 0.00% | – |
| Q1 2020 | $71,000 | -61.0% | 11,373 | -5.5% | 0.00% | -100.0% |
| Q4 2019 | $182,000 | +46.8% | 12,030 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $124,000 | -32.2% | 12,131 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $183,000 | +21.2% | 12,382 | +34.7% | 0.00% | 0.0% |
| Q1 2019 | $151,000 | +906.7% | 9,189 | +260.8% | 0.00% | – |
| Q4 2018 | $15,000 | -53.1% | 2,547 | -4.9% | 0.00% | – |
| Q3 2018 | $32,000 | – | 2,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 8,008,204 | $121,404,000 | 75.69% |
| Casdin Capital, LLC | 3,098,121 | $46,968,000 | 4.32% |
| Alphabet Inc. | 3,339,138 | $50,621,000 | 3.06% |
| Eventide Asset Management | 3,393,894 | $51,451,000 | 1.45% |
| Opaleye Management Inc. | 449,950 | $6,728,000 | 1.32% |
| GILDER GAGNON HOWE & CO LLC | 4,103,425 | $62,208,000 | 0.65% |
| HARVARD MANAGEMENT CO INC | 332,610 | $5,042,000 | 0.53% |
| Values First Advisors, Inc. | 21,844 | $331,000 | 0.32% |
| MYDA Advisors LLC | 22,000 | $334,000 | 0.15% |
| Aries Wealth Management | 12,000 | $177,000 | 0.11% |